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Abstract
Background: Adenovirus serotype 5 (Ad5) has many favourable characteristics for development as a gene therapy
vector. However, the utility of current Ad5 vectors is limited by transient transgene expression, toxicity and
immunogenicity. The most promising form of vector is the high capacity type, which is deleted for all viral genes.
However, these vectors can only be produced to relatively low titres and with the aid of helper virus. Therefore a
continuing challenge is the generation of more effective Ad5 vectors that can still be grown to high titres. Our
approach is to generate complementing cell lines to support the growth of Ad5 vectors with novel late gene
deficiencies.
Results: We have used LoxP/Cre recombination mediated cassette exchange (RMCE) to generate cell lines
expressing Ad5 proteins encoded by the L4 region of the genome, the products of which play a pivotal role in
the expression of Ad5 structural proteins. A panel of LoxP parent 293 cell lines was generated, each containing a
GFP expression cassette under the control of a tetracycline-regulated promoter inserted at a random genome
location; the cassette also contained a LoxP site between the promoter and GFP sequence. Clones displayed a
variety of patterns of regulation, stability and level of GFP expression. Clone A1 was identified as a suitable parent
for creation of inducible cell lines because of the tight inducibility and stability of its GFP expression. Using LoxP-
targeted, Cre recombinase-mediated insertion of an L4 cassette to displace GFP from the regulated promoter in
this parent clone, cell line A1-L4 was generated. This cell line expressed L4 100K, 22K and 33K proteins at levels
sufficient to complement L4-33K mutant and L4-deleted viruses.
Conclusions: RMCE provides a method for rapid generation of Ad5 complementing cell lines from a pre-selected
parental cell line, chosen for its desirable transgene expression characteristics. Parent cell lines can be selected for
high or low gene expression, and for tight regulation, allowing viral protein expression to mirror that found during
infection. Cell lines derived from a single parent will allow the growth of different vectors to be assessed without
the complication of varying complementing protein expression.
Background
Currently, 24% of gene therapy clinical trials worldwide
are using adenovirus serotype 5 (Ad5) as the delivery
vehicle [1]. First generation Ad5 vectors were created by
deletion of the genes for the viral transactivator (E1A)
and E1B proteins to render the vector replication-
incompetent and deletion of the E3 genes, the products
of which are non-essential for in vitro growth [2]. These
vectors have capacity for up to ~7 kbp transgene
sequence, can grow to high titres in E1-complementing
cells and have the ability to infect a wide range of cells.
However, although the ability of these vectors to repli-
cate is significantly inhibited compared to wt virus, they
still exhibit low levels of viral late protein expression,
and transgene expression in vivo is only transient [2].
This is in part because the vector DNA does not inte-
grate and therefore has no mechanism of maintenance
in a dividing cell population. However, transience is pri-
marily due to the elimination of cells by the initiation of
an immune response to viral vector gene expression
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more completely replication-incompetent by the further
mutation of E2 or E4 genes [4-6]. Whilst these give
improved persistence of transgene in vivo because of
reduced immune responses, the stability and level of
transgene expression is variable [7-11]. The most pro-
mising Ad5 vectors for long-term gene delivery in vivo
have been those that do not contain any viral coding
sequence [12,13]. However, to grow these gutted vec-
tors, they must be complemented with helper viruses as
no cell line expressing the full array of viral proteins is
available; although yields of vector from such systems
can be high, there is the additional problem that the
helper virus must be inactivated or removed before the
vector can be used and residual contamination with
helper is likely [14,15]. Therefore, a vector which
retained the practical advantages of earlier Ad5 vectors
but displayed further reduced viral gene expression and
hence induced less toxicity and reduced inflammatory
and immune responses would be an ideal gene delivery
vehicle. For reviews on adenovirus vectors see [14,16].
The Ad5 L4 region encodes three non-structural pro-
teins, L4-100K, -22K and -33K, which have been shown
to be essential for structural protein expression in the
late phase of infection. L4-22K acts both at the level of
transcription and post-transcriptionally to support late
mRNA production [17]. In addition, this L4 protein has
been shown to be a packaging factor [18]. L4-33K is a
splice factor that is essential for production of a subset
of late mRNAs [19,20]. L4-100K is responsible for selec-
tive translation of late mRNAs [21] and for the stabilisa-
tion and assembly of hexon trimers, which form the
major part of the capsid of progeny particles [22]. As
might therefore be expected, an L4 100K-mutated, E1
-,
E3
- vector was previously reported to have reduced liver
toxicity in mice [23]. A vector deleted for all three L4
proteins would still retain the ability to replicate its
DNA, and hence to express transgenes to high level, but
would be further improved by being unable to produce
any of the late structural proteins associated with toxi-
city and the induction of an inflammatory response.
The propagation of new adenovirus vectors is depen-
dent upon the creation of cell lines to provide the pro-
teins necessary for virion production that the vector is
unable to encode. The classic method for generating
Ad5 vector complementing cell lines is to transfect cells
with a construct containing the viral gene under the
control of either its own or a heterologous promoter
and to select for cells stably expressing the viral protein,
either directly or via a co-transfected or linked anti-
biotic-resistance gene. This method relies on the inte-
gration of the complete construct in one or a few
random positions within the chromosome. The site of
integration of such expression cassettes affects expres-
sion of the inserted gene as gene expression in mamma-
lian cells is controlled by chromatin structure [24].
Chromatin remodelling within the transgene, imposed
by the adjacent chromatin structure, can result in pro-
moter silencing [25]. Therefore, a large number of cell
lines must be isolated and characterised to identify one
that has the desired expression characteristics, which
can be inconvenient and time consuming. Furthermore,
many proteins, including in our experience L4-100K, are
toxic to cells when over-expressed. To obtain cell lines
expressing such proteins requires gene expression to be
made tightly inducible, thus adding another trait which
needs to be tested in potential cell lines. L4-100K cyto-
toxicity likely reflects its effects on host cell translation;
this toxicity may explain the very low level of 100K
expression previously achieved by standard cell line
techniques [23].
Recombination-mediated cassette exchange (RMCE)
using LoxP/Cre-mediated recombination [26-28] has
been used previously for a wide range of applications
including: engineering cell lines to express high levels of
recombinant proteins [29,30]; generating cell lines to
study panels of mutant proteins [31]; and generating
transgenic stem cell lines [32]. RMCE relies on the pre-
insertion into the chromosome of a cassette that
contains a LoxP site placed between the promoter and
coding sequence of a marker gene. Cell clones with the
desired characteristics of marker gene expression are
first isolated and then used as the parent for insertion of
the gene of interest at the LoxP site by Cre-mediated
recombination; at the same time the marker gene is dis-
placed from the promoter. Each resulting clone should
have the same characteristics of expression as the mar-
ker gene in the parent cell line, because the site of inser-
tion into host chromatin will be identical. Chromosomal
positioning effects and silencing of the transgene are
therefore avoided. Although the initial workload to iso-
late and characterise the parent cell lines is equal to
that used in the conventional method, the choice of an
appropriate marker gene can speed up the screening
process and, once generated, such cell lines can be used
to generate multiple complementing cell lines with reli-
able expression characteristics.
Here we report the use of LoxP/Cre RMCE to gener-
ate an inducible Ad5 L4-complementing cell line. First,
a panel of GFP LoxP parent cell lines was generated
and characterised with respect to the inducibility and
stability of GFP expression. One parent cell line,
selected for its favourable properties, was then used to
generate a cell line that expressed Ad5 L4 proteins and
was able to support productive infection of L4-mutant
viruses.
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Generation of LoxP parent cell lines
293 cells are Ad5 E1-complementing cell lines that sup-
port the growth of E1
- Ad5 vectors to high titres [33].
A derivative of these cells, 293TETOFF, which constitu-
tively expresses the tetracycline transactivator protein
tTA, was used as the starting point for the work, with
the aim of isolating cell lines exhibiting regulated trans-
gene expression. The overall strategy for creation of
Ad5 L4-expressing cell lines from 293TETOFF cells by
LoxP/Cre RMCE is shown in Figure 1A. 293TETOFF
cells were first transfected with pLoxPGFP, which car-
ries GFP under the control of the tetracycline-regulated
PBi promoter, and selected for Zeocin resistance.
A population of cells was obtained that had a broad
range of GFP expression levels in the absence of the tet-
racycline analogue, doxycycline (Dox) (Figure 1B,
unsorted); 66% of the population showed little or no
GFP expression (< 10 fluorescent units, f.u.). Preliminary
experiments had indicated that clones expressing low
levels of GFP (10-100 f.u.) typically lost transgene
expression by 40 days of selection, probably due to
chromatin remodelling and promoter silencing since
they remained Zeocin-resistant (data not shown). There-
fore, to enrich for cells that might subsequently show
stable GFP expression and to reduce the number of
cells that were not expressing GFP prior to isolating sin-
gle-cell clones, the Zeocin-resistant population was
sorted into low GFP expression (10-100 f.u.) and high
GFP expression (100-10,000 f.u.) populations (Figure
1B). The proportion of cells that did not express GFP in
these sorted populations was reduced to 30% and 16%
respectively. Individual cell clones (LoxP parent lines)
were then isolated from the high-expressing population.
LoxP parent cell lines show varying GFP regulation and
expression
The GFP expression characteristics of LoxP parent
clones was expected to vary because regulation of the
PBi promoter by Dox is dependent upon the site of inte-
gration within the chromosome [34]. We wished to
obtain a LoxP parent clone that displayed very low basal
expression in the presence of Dox, good inducibility
upon Dox removal and long-term stability of this indu-
cible expression. 41 LoxP parent cell clones were iso-
lated and tested for their level and regulation of GFP
expression; Figure 2A shows a representative selection
of these clones. All clones except B16 expressed levels
of GFP (induced upon Dox withdrawal) in the range of
100-10,000 f.u., as expected since they were isolated
from the high-expressing sorted population (Figure 1B).
21 clones exhibited tight regulation of GFP expression
by Dox, e.g. clones A1 and A7 (Figure 2A); tight regula-
tion was defined as less than 5% of cells expressing >10
f.u. GFP (out background cut-off set for non-fluorescent
293TETOFF cells) under conditions of Dox-mediated
repression of the GFP transgene. The other 20 clones,
in contrast, showed leaky expression in the presence of
Dox, e.g. clones A12, B3 and B8 (Figure 2A).
Clone B3 appeared to comprise of two distinct popu-
lations, one expressing and one not expressing GFP
upon induction (Figure 2A). To determine whether B3
was in fact not clonal or alternatively if its GFP
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Figure 1 Select and insert strategy for cell line generation.
(A) Diagram showing the select and insert strategy used to
generate L4 complementing cell lines. LoxP parent cell lines are first
isolated by selection for Zeocin resistance and characterised for
their inducible expression of GFP. Cre-mediated recombination is
then used to replace the GFP gene from LoxP parent cells with an
L4 cassette from a promoterless shuttle plasmid. (B) To generate
LoxP parent cells, 293TETOFF were transfected with pLoxPGFP and
Zeocin-resistant cells were sorted by FACS into two populations
based on GFP fluorescence intensity. Left: unsorted cell population;
centre: cells sorted for low to medium GFP expression; right: cells
sorted for high GFP expression.
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into expressing and non-expressing populations and
GFP expression in the expressing population analysed
over 55 days. This revealed that B3 GFP expression was
unstable, since the proportion of cells induced to
express GFP decreased from 90% at day 0 post-sorting
to 86% at day 30 and 25% at day 55 (Figure 2B). This
instability may be due to heterochromatin assembly on
the transgene promoter imposed by the integration
context.
Characterisation of LoxP parent cell line Clone A1
Clone A1 was picked as a potential LoxP parent line
from which to generate Ad5 L4-complementing cell
lines due to its tight regulation and good inducibility,
hence its properties were analysed further. To assess
how quickly Clone A1 accumulated GFP after the
removal of Dox, the cells were grown in the presence or
absence of Dox for 3, 7, 14 or 18 days (Figure 3A).
3 days post Dox removal, 36% of cells expressed GFP,
increasing to 70% by day 7 and peaking at 75% by day
14 after the removal of Dox. The low level of recovery
of expression by day 3 reflects the difficulty in removing
Dox from the cell system, even with daily media washes
[35]. Greater than 70% of the cell population expressed
GFP for over 11 days showing that transgene expression
was stable and prolonged in the absence of Dox. These
properties of Clone A1 were stable during 60 days of
growth under conditions of Dox repression, with tight
promoter regulation in the presence of Dox and a good
level of inducible expression of GFP upon Dox withdra-
wal being maintained throughout (Figure 3B). This level
and duration of expression, applied to an Ad5-comple-
menting transgene, should be more than adequate
for the growth of adenovirus vectors, which have a
24-36 hour replication cycle in complementing cells and
produce plaques within 7-9 days.
To be useful as a parent for cell line generation by a
RMCE strategy, it was important that Clone A1 cells
contained only one copy of the LoxP-GFP cassette,
A1 A7 A12 B8 B16 B3 0
0
v GFP Fluorescence Intensity
N
u
m
b
e
r
 
o
f
 
C
e
l
l
s
+
 
d
o
x
-
d
o
x
A.
N
u
m
b
e
r
 
o
f
 
C
e
l
l
s
GFP Fluorescence Intensity
day 30
Peak B
day 55
Peak B
Unsorted Sorted day 0
Peak A
Sorted day 0
Peak B
A
30%
B
70% 14% 86%
10% 90% 14% 86% 75% 25%
B.
Figure 2 Analysis of LoxP parent cell lines. (A) Clones from the high GFP-expressing pool (Figure 1B) were grown in the presence of 100 ng/
ml Dox. Media containing Dox was removed 7 days prior to analysis and media changed daily before GFP expression analysis by FACS. (B)
Clone B3 contained two sub-populations (A = not expressing GFP; B = expressing GFP), which were separated by FACS. The ability of Clone B3-B
cells to be induced to express GFP was analysed at day 0 post-sorting, day 30 and day 55, with Dox removal at each time point as panel A.
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the transgene. To test this, genomic DNA from Clone
A1, and Clone A12 included for comparison, was ana-
lysed by Southern blot using a probe for the GFP gene
(Figure 3C). This probe, which gave specific hybridisa-
tion since control cell 293TETOFF DNA gave no bands,
detected the expected fragments of 4.1 kbp and 5.1 kbp
in EcoRI and KpnI digests of the input plasmid
pLoxPGFP. Clone A1 DNA also gave single probe-speci-
fic fragments in the two digests, however these were in
each case larger than the equivalent fragments from the
input plasmid. The increase in size results from the link-
ing of probe target sequence in the plasmid to genomic
DNA to create hybrid EcoRI and KpnI fragments. The
fact that there was only one such fragment in each
digest from the Clone A1 cells indicated that a single
integration event had occurred. Clone A12 DNA also
gave single major bands in each of the two digests with
sizes distinct from those in both Clone A1 and the plas-
mid control, indicating the presence of a different single
integration site in this clone. Two weak additional bands
from the A12 EcoRI digest probably arose from incom-
plete digestion. We did not assess the proportion of iso-
lated clones that carried single insertions of the
regulated hrGFP cassette, however the fact that two ran-
domly selected clones had single inserts suggests this
frequency was high.
Generation of A1-L4 cell lines
The L4 region of Ad5 is part of the major late transcrip-
tion unit (MLTU) and is expressed from the major late
promoter (MLP) during the late phase of infection [36].
Specific mRNAs able to encode L4-100K, -22K or 33K
are generated from a single primary transcript by alter-
native splicing, which links the relevant 3’ exons to a tri-
partite leader sequence (TPL; common to all MLTU
mRNAs) comprised of leaders 1, 2 and 3 (Figure 4A).
The TPL allows selective translation of mRNA late in
infection when host cell shutoff has been initiated
[37,38]. To allow creation of inducible L4 cells from
LoxP parent Clone A1, a promoterless L4 cassette suita-
ble for Cre-mediated insertion was designed that
included the L4-100K, -22K and -33K ORFs. The cas-
sette also included a 5’ TPL sequence and, as spliced
mRNAs are exported more efficiently from the nucleus
than unspliced mRNAs [39], a 306 bp internally trun-
cated intron comprising the TPL leader 3 splice donor
and the L4-100K splice acceptor sites (Figure 4B).
Clone A1 cells were transfected with a plasmid con-
taining this cassette (pShuttle100/22/33KFLAG) and
pCre to give hygromycin-resistant L4-expressing cells by
Cre-mediated recombination. In the uncloned popula-
tion of A1-L4 cells, analysed 21 days after selection,
only 27% of cells expressed GFP 3 days after the
removal of Dox compared to 66% of the parental cells
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daily media changes before GFP analysis by FACS. (B) Clone A1 was maintained for 60 days in the presence of Dox before removal 7 days
prior to analysis of GFP expression. (C) Clone A1, Clone A12, or control 293 TETOFF cell genomic DNA, or pLoxPGFP plasmid DNA (+ve) was
digested with EcoRI or KpnI and analysed by Southern blotting using a GFP gene probe. The positions to which DNA size markers migrated
are indicated (kbp).
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nied by the gain of L4-100K expression as detected by
western blotting (Figure 4D). This pattern of gene
expression is consistent with insertion of the L4 cassette
at the LoxP site as planned.
To confirm that the L4 cassette had been inserted
downstream of the PBi promoter, a single cell clone,
Clone A1-L4, was isolated from the A1-L4 population
for further characterisation. Genomic DNA from Clone
A1-L4 and from its parent A1 was used as template to
amplify a PCR product using primers designed against
PBi and TPL leader 3 within the L4 cassette. A product
will only be obtained if the TPL-L4 cassette is in the
correct location so as to bring these two primer binding
sites, one from the A1 parent and one from the shuttle
plasmid, into proximity. A product of the expected size,
441 bp, was amplified from Clone A1-L4 but not Clone
A1 genomic DNA (Figure 4E). Taken together, these
data show that recombination has occurred between the
genomic DNA and the shuttle plasmid, resulting in the
displacement of the GFP gene from the tetracycline-
regulated promoter.
L4-100K can only be expressed from the L4 cassette
via the PBi promoter and thus its expression and
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Figure 4 Generation of A1-L4 cell lines. (A) The Ad5 major late transcription unit L4 region. During expression from the major late promoter
(MLP), leaders 1, 2 and 3 (the tripartite leader; TPL) are spliced to alternative acceptor sites to generate L4 mRNAs encoding 100K, 22K, 33K and
the structural protein pVIII; L4-22K and -33K proteins share the same N-terminus but have distinct C-termini due to the presence of an intron in
the L4-33K ORF. L4-22K and -33K are also expressed from the L4 promoter early in infection. (B) The L4 cassette within pShuttle100/22/33KFLAG,
used for RMCE to generate the A1-L4 cell population. Numbers indicate Ad5 genome positions. LoxP: DNA target sequence for Cre recombinase;
FLAG: C-terminal epitope tag on the 33K open reading frame; Hyg
R; hygromycin-resistance gene. (C) 293TETOFF, Clone A1 and the uncloned
A1-L4 population, 21 days post-recombination, were grown without Dox for 3 days with daily media changes and the level of GFP analysed by
FACS. M1 shows the percentage of cells expressing GFP above the threshold set by 293TETOFF cell background fluorescence. (D) Clone A1 cells
and the uncloned A1-L4 cell population were analysed for L4-100K expression by western blot analysis. The positions to which proteins of
known molecular mass migrated are indicated (kDa). (E) To confirm correct insertion of the L4 cassette in clone A1-L4 obtained from the A1-L4
population, genomic DNA from these and control (A1) cells was used as template for PCR amplification using one primer to the tetracycline-
regulated PBi promoter and another to the leader 3 sequence within the TPL of the L4 cassette; -ve, PCR negative control. All lanes shown
derive from the same exposure of a single gel with irrelevant lanes excised for clarity of presentation. The positions to which DNA size markers
migrated are indicated (bp).
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GFP in Clone A1. However, L4-22K and L4-33KFLAG
can also be expressed from a recently identified L4 pro-
moter located within the L4-100K ORF (Figure 4A) and
so should be constitutively expressed [40]. To confirm
these patterns of expression, Clone A1-L4 cells were
examined by immunofluorescence (Figure 5). As
expected, L4-100K was expressed in an inducible man-
ner (compare panels i, j with m, n). L4-33KFLAG was
also detected but its expression was not repressed by
Dox (compare panels k, l, with o, p) consistent with
expression occurring from the L4 promoter. L4-
33KFLAG fluorescence was not significantly increased
in the absence of Dox compared to levels in the pre-
sence of Dox, implying either that expression of L4-
33KFLAG from the inducible PBi promoter is low in
comparison with its expression from the L4 promoter or
that expression from the PBi promoter inhibits and
therefore replaces expression from the L4 promoter
once Dox repression is removed. In the first case, it is
possible that alternative splicing of PBi-derived tran-
scripts does not favour production of 33K mRNA,
although it is clear that MLTU splicing in the natural
context can give 33K expression [40]. In the second
case, expression from the L4 promoter may be inhibited
by competition with PBi for cellular transcription factors
or by promoter occlusion from overriding PBi-derived
transcription, or else translation of 33KFLAG from L4
promoter-derived mRNAs may be inhibited in the pre-
sence of L4-100K expressed from PBi b e c a u s et h e yl a c k
a TPL sequence [21]. Although L4-22K protein expres-
sion from Clone A1-L4 was not tested as no specific
antibody was available, it would be expected that
this protein, which shares the same start site as
L4-33KFLAG and is expressed from the same L4 pro-
moter, should resemble L4-33K in its expression.
Equivalent constructs have been shown to express func-
tional levels of L4-22K in another context [40].
Only a low frequency of L4-100K expressing cells was
detected by immunofluorescence (Figure 5m, n). This
may be as a consequence of the cytotoxicity of L4-100K,
although cells were fixed and stained only 3 days after
Dox removal to avoid any excessive cell death due to
overexpression of L4-100K. In contrast, L4-33KFLAG
was detected in 100% of cells and, as expected from the
FACS analysis of the uncloned A1-L4 pool (Figure 3),
Clone A1-L4 did not express GFP under any conditions,
unlike Clone A1 which expressed GFP in the absence
but not in the presence of Dox (Figure 5c, d, g). Both
these findings confirmed that the Clone A1-L4 cells
were homogeneous with respect to other aspects of
transgene expression. Since L4-100K expression was
assessed only 3 days after Dox withdrawal, a time when
the proportion of equivalently treated parent A1 cells
expressing GFP ranged from 36-66% (Figure 3A &
Figure 4A), the most likely interpretation of the low fre-
quency of 100K expression is that it reflects incomplete
recovery following Dox-removal and hence, under con-
ditions where Dox has been fully removed, all cells of
Clone A1-L4 should express L4-100K.
Clone A1-L4 expresses functional levels of L4 proteins
Having isolated Clone A1-L4 and shown it expressed
detectable amounts of L4 proteins, we now wished to
show that these proteins could offer functional comple-
mentation of L4 deficiencies. We previously showed that
full late gene expression from plasmid pBiL1-3, which
contains the TPL and MLTU regions L1-3 under the
control of the PBi promoter, required L4-22K, -33K and
-100K proteins in trans [17,19]. Therefore, to examine
the functionality of the L4 proteins expressed by Clone
A1-L4, the ability of this cell line to support full late
gene expression from pBiL1-3 plasmid was investigated.
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Figure 5 Analysis of Clone A1-L4 gene expression.P r o t e i n
expression from Clone A1-L4 was analysed by fluorescence
microscopy. 293TETOFF (a, b, e & f), Clone A1 (c, d, g & h) and
Clone A1-L4 cells (i-p) were grown in the presence (a-d & i-l) or
absence (e-h & m-p) of Dox for 3 days with daily media changes.
Cells were fixed and stained for L4-100K (red, i, j, m & n) or FLAG-
tagged L4-33K (red, a-h, k, l, o & p) and nuclear DNA (DAPI, blue)
and visualised using a Leica SP2 confocal microscope. GFP
autofluorescence was also imaged (green). Images b, d, f, h, j, l, n &
p are overlays in Leica software of the L4-100K or L4-33KFLAG
images with GFP and DAPI images, collected sequentially to avoid
cross-talk between fluors.
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Figure 6 Clone A1-L4 expresses functional levels of L4 proteins. (A) 293TETOFF or Clone A1-L4 cells were transfected with pBiL1-3 and
either pCMVFLAG (empty vector; [19]) or L4-22/33KFLAG or L4-100KFLAG expression plasmids. Cell lysates were separated on 10%
polyacrylamide gels and expressed proteins detected by western blot analysis using AbJLB1 anti-late protein antisera. All lanes shown derive
from the same exposure of a single blot with irrelevant lanes excised for clarity of presentation. The positions to which proteins of known
molecular mass migrated are shown on the left (kDa). (B) 293TETOFF or Clone A1-L4 cells were grown in the presence (g-l) or absence of Dox
(a-f & m-x) for 3 days with daily media changes prior to mock infection (a-c) or infection with P2 WT (d-f), Δ47 (g-r) or ΔL4 (s-x) viruses. Cells
were fixed and stained 20 h.p.i. for Ad5 DNA binding protein (DBP) (green; b, e, h, k, n, q, t & w) or Ad5 late proteins (red; c, f, i, l, o, r, u & x)
and nuclear DNA (DAPI, blue) and visualised using a Leica SP2 confocal microscope. Images a, d, g, j, m, p, s & v are overlays in Leica software of
DBP, late protein and DAPI images, collected sequentially to avoid cross-talk between fluors. (C) To confirm the ΔL4 virus genotype, Ad5 23863-
27086 bp region was amplified by PCR from DNA isolated from either ΔL4 or wt virus particles. ΔL4A and ΔL4B reactions contained 1 and 4 μg
viral genomic DNA respectively as template; -ve, PCR negative control. The positions to which DNA size markers migrated are indicated (kbp).
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L2-V expressed from the plasmid was greater in Clone
A1-L4 than 293TETOFF cells (Figure 6A) showing that
functional levels of the L4 proteins were produced.
However, this late protein expression was still limited,
and could be further increased by the co-transfection of
an L4-22K/33KFLAG expression plasmid to provide
additional L4 protein (Figure 6A), indicating that levels
of 22K and/or 33K in A1-L4 cells were limiting. Hexon
was produced under these conditions, which indicated
that the level of L4-100K (specifically required for
hexon accumulation) was not a limiting factor. This
conclusion is further supported by the fact that hexon
protein levels expressed from pBiL1-3 in Clone A1-L4
cells were similar in the presence and absence of addi-
tional exogenous L4-100K (Figure 6A). Thus Clone A1-
L4 cells express functional levels of L4 proteins.
To investigate whether Clone A1-L4 could comple-
ment L4 mutations in virus, linear wild-type (WT) or
L4-mutant viral genomes were transfected into 293TET-
OFF or Clone A1-L4 cells. WT genome induced a cyto-
pathic effect (cpe), indicative of productive infection, in
both cell types. The L4-33K mutant genome Δ47 [41]
induced cpe in Clone A1-L4 cells only, both in the pre-
sence and absence of Dox, but to a lesser extent under
the former conditions (data not shown). This was
expected as the complementing protein for Δ47,
L4-33K, is produced under both these conditions
(Figure 5). In contrast, cpe induced by the ΔL4 mutant
genome, which requires complementation by L4-100K,
-22K and -33K, was only observed in Clone A1-L4 cells
in the absence of Dox (data not shown). Collectively,
these data suggested that Clone A1-L4 could provide
functional complementation for L4 deficiencies.
To confirm this, and to determine if infectious virus
had been produced in these transfections, second pas-
sage stocks of Δ47, ΔL4 and WT viruses that had been
recovered from the genome transfections described
above were used to infect cells that were then analysed
for early and late viral antigens by immunofluorescence.
The stocks were used untitred because the complement-
ing A1-L4 cells could not be sustained under agar as
required for a plaque assay. Infections of complementing
(A1-L4) and non-complementing cells (293TETOFF)
were compared to confirm that the intended virus had
been rescued without reversion (Figure 6B).
WT virus expressed DNA binding protein (DBP) from
the E2A gene in distinctive foci within the cell nuclei that
are indicative of active replication [42]; it also expressed
a high level of late proteins as expected of a normally
progressing infection 20 hours post-infection (h.p.i.;
Figure 6B panels a-c). Δ47 virus in control 293TETOFF
cells, either in the presence (Figure 6B panels g-i) or the
absence of Dox (Figure 6B panels m-o), expressed large
amounts of DBP but only low levels of late proteins.
Moreover, DBP staining was either diffuse in the cell
nuclei or present in one large replication centre per cell,
indicating that infection was stalled at an early stage. Δ47
gave a similar pattern of expression in Clone A1-L4 cells
under conditions of PBi repression (+Dox; Figure 6B
panels j-l), even though L4-33K is expressed from the L4
promoter under these conditions. This result suggests
that the amount of L4-33K expressed from the L4 pro-
moter alone is not sufficient for efficient propagation of
Δ47 virus, and correlates with the lower level of cpe
observed in cells transfected with Δ47 genome in the pre-
sence of Dox than in its absence. The fact that a low level
of late protein expression was observed from Δ47 virus
under these non-complementing conditions was
expected as Δ47 genome has previously been reported to
express some late proteins, in particular 100K and hexon
[41]. In complete contrast, in Clone A1-L4 cells where
L4 expression from PBi was induced by the removal of
Dox, Δ47 virus-infected cells expressed DBP that was
incorporated into numerous replication centres and also
produced high levels of late proteins (Figure 6B panels
p-r). The number of replication centres and level of late
protein staining was similar to that of WT virus, showing
that the transition between early and late phase infection,
for which L4-33K is required, had occurred. Taken
together, these data show that Clone A1-L4 can comple-
ment an L4-33K-defective Ad5 when L4 protein expres-
sion from the cell line is induced by Dox removal.
ΔL4 virus produced numerous DBP-containing repli-
cation centres in 293TETOFF and Clone A1-L4 cells
(Figure 6B panels s-u and v-x), similar to WT virus and
indicating that the infection had entered the late phase.
From our previous data showing that the L4 proteins
are essential for late gene expression, and the need for
complementation from A1-L4 cells for ΔL4 genome
to cause cpe, these ΔL 4v i r u si n f e c t i o n sw e r ee x p e c t e d
to be completely defective in late gene expression in
non-complementing cells.H o w e v e r ,a l t h o u g hm o s t
ΔL4-infected (DBP-expressing) cells showed the
expected absence of late proteins in contrast to WT
virus (Figure 6B panel d), a minority of the ΔL4-infected
cells expressed a significant amount of late proteins.
O n ep o s s i b l ee x p l a n a t i o nf o rt h i sw a st h ep r e s e n c eo f
some WT virus in the ΔL4 virus stock arising by rever-
sion during virus isolation. To confirm that this was not
the case, a PCR was performed on purified packaged
DNA from a ΔL4 infection. Using primers spanning the
L4 region, a band of 781 bp was amplified from ΔL4
compared to 3223 bp from WT. Absence of this 3.2 kbp
band in ΔL4 reactions showed there was no detectable
WT contamination in the ΔL4 stock and that ΔL4 virus
defective in L4-100K, -22K and -33K had therefore been
grown successfully using Clone A1-L4 cells.
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Recent advances in our understanding of basic adeno-
virus biology have led to the possibility of generating
vectors deleted in the regulatory proteins, L4-100K,
-22K and -33K, that are now known to be required for
structural protein expression. In theory such vectors
would have reduced toxicity and immunogenicity as
they would be unable to express the immunogenic vir-
ion proteins within transduced cells [17]. However, the
propagation of L4-deficient vectors is reliant upon
the development of cell lines that are able to support
the growth of these replication incompetent vectors in
vitro. Using conventional methods to generate cell lines
expressing a heterologous protein results in the random
integration of one or several copies of an expression cas-
sette into the genome and the level and stability of
expression is then subject to chromosomal positioning
e f f e c t s .I nt h i ss t u d yw ed e p l o y e daL o x P / C r eR M C E
strategy to overcome this problem and produce a cell
line capable of inducibly expressing Ad5 L4 proteins.
The design of the RMCE system used here was care-
fully considered to maximise the potential for success.
Firstly, humanised Renilla reniformis GFP was used as
the reporter gene to screen LoxP parent cell lines as it
has been reported that this form of GFP is less toxic
than enhanced GFP or its relatives [43], thus permitting
long term expression. This was an important factor as
the selection process used required long periods of GFP
expression without being compromised by cytotoxicity.
Secondly, due to the potential toxicity of viral L4 genes
to be expressed by the eventual cell line, the tetracy-
cline-regulated promoter, PBi, was chosen to drive trans-
gene expression. This promoter, which comprises
multiple copies of tetO, the recognition site for tetracy-
cline transactivator protein tTA, and a minimal CMV
promoter [44], gives expression that is tightly repressed
in cell lines containg tTA in the presence of tetracycline
or Dox and which can be strongly induced upon Dox
withdrawal. Thirdly, the Zeocin and hygromycin resis-
tance genes were placed under the control of the rela-
tively weak herpes simplex virus tk promoter to limit
potential effects on PBi regulation of having a constitu-
tive promoter located in close proximity within the
inserted construct. Fourthly, the L4 cassette for transfec-
tion into GFP-expressing parent cells was designed so
that the L4 mRNAs produced from it would resemble
those seen in an Ad5 infection, thus maintaining the
natural stability, processing and transport of these
mRNAs. Finally, the absence of a promoter from the L4
cassette limited the potential for cytotoxicity due to
expression of L4-100K during cell line isolation, either
from unintegrated plasmid or due to random integration
of the plasmid into the genome at sites other than the
intended, regulated expression site.
The first stage in an RMCE protocol is equivalent to
standard cell line generation methodology, and here
resulted in a population of Zeocin-resistant cells with a
broad range of GFP fluorescence expression characteris-
tics from which individual cell clones were isolated and
characterised. To reduce the work involved in identify-
ing clones with appropriate expression characteristics
for use as LoxP parent cell lines in this study, the Zeo-
cin-resistant population was initially sorted by FACS,
based on the level of induced GFP expression, prior to
isolating individual clones. This step enriched the
uncloned population for cells where the hrGFP gene
had been integrated into transcripionally active regions.
It would also be possible to further enhance the effi-
ciency of the screening process by adding an additional
sorting step to eliminate cells which exhibited leaky
gene regulation under conditions of Dox-mediated
repression.
41 LoxP parent clones were isolated and screened,
98% of which expressed GFP. The level and stringency
of regulation of GFP expression was shown to be clone-
specific. It has previously been reported that when this
system of regulation is used in 293 cells, protein expres-
sion is detected at low levels even in the presence of
D o x[ 3 4 ] .H e r et o o ,t h eP Bi promoter in most of the
LoxP parent cell lines that exhibited what we defined as
tight regulation also had a very low activity in the pre-
sence of Dox (Figure 2A). Even tighter regulation might
be achieved by using as the parent cell line something
other than 293 cells, since variability in basal activity of
PBi between cell lines has been reported [45]. However
it was necessary to use 293 cells for this study as they
constitutively express the Ad5 E1 proteins that are
required for the propagation of E1
- vectors, which
would form the genetic backbone of any new L4-defi-
cient Ad5 vector construct.
Although insertion of L4 at the LoxP site of LoxP par-
ent clone A1 should abolish GFP expression, some
GFP-expressing cells were seen in the uncloned A1-L4
population. Cre-mediated recombination between LoxP
sites in a circular plasmid and the target chromosome
results in the inserted DNA being flanked by LoxP sites,
meaning that re-excision of the inserted gene can occur
by the further action of Cre recombinase [27]. This flip-
ping effect may account for the presence of these few
GFP
+ c e l l s .T h ec o p yn u m b e ro fp C r ea n dt h u st h e
amount of Cre recombinase in the transfected cells dur-
ing isolation of an expressing cell population should
reduce progressively over time through cell division,
leading eventually to a stable position. Moreover,
Morris et al. BMC Biotechnology 2010, 10:92
http://www.biomedcentral.com/1472-6750/10/92
Page 10 of 14ongoing growth in the presence of hygromycin gives
selection pressure for cells that do not harbour Cre
recombinase as this will permit the stable retention and
expression of the hygromycin resistance gene. However,
there remains the possibility that in a small number of
cells Cre recombinase could become stably integrated,
giving rise to ongoing transgene instability. An alterna-
tive explanation for the residual GFP-expressing cells in
the uncloned A1-L4 population is that non-resistant
cells simply required longer exposure to hygromycin to
achieve cell death. No GFP expression was observed in
Clone A1-L4 cells, indicating that the recombination
event that gave rise to this cell line was stable.
The level of L4-100K expression in Clone A1-L4 cells
was substantial, and apparently was not limiting for
complementation within the tests performed here. Pre-
viously, a cell line expressing very low levels of 100K
was able to complement a 100K-mutated vector for
growth to high titre [23], suggesting only low amounts
of 100K are required. However, the 100K mutation
employed in that study was an in-frame deletion of resi-
dues 315-543 within the 807 residue protein and so may
not have been defective for all functions of this multi-
functional protein. Substantial amounts of 100K are
made during Ad5 infection, so higher levels of 100K are
likely to be important for some aspects of its function.
A l t h o u g hC l o n eA 1 - L 4c e l l sw e r ea b l et op r o v i d e
functional levels of L4-100K, -33K and -22K in two
assay systems, the amount of L4-22K and L4-33K
appeared to be limiting. This was surprising as these
two proteins can be expressed from a natural promoter,
the L4-promoter, located within L4-100K ORF and
therefore, unlike L4-100K, their expression is not subject
to inhibition by Dox. However, we have previously
shown that the L4-promoter is activated by early and
intermediate viral proteins and by viral genome replica-
tion [40]. Since none of these was present in the func-
tionality assay utilising pBiL1-3 in this study, activity of
this promoter would have been suboptimal. The L4-pro-
moter should have been maximally active in the gen-
ome/virus complementation experiments however,
despite this, Clone A1-L4 cells did not appear to sup-
port the growth of Δ47 virus unless full expression of
the L4 cassette from PBi was induced by Dox removal.
Whilst some cpe was observed for cells transfected with
Δ47 genome in the presence of Dox, this was less than
that seen when Dox was washed out of the system. This
is the first time Δ47 virus [41] has been grown from its
cloned genome as a complementing cell line was not
previously available.
Growth of ΔL4 virus also depended on the use of
complementing A1-L4 cells. When ΔL4 virus was used
to infect non-complementing cells, it gave significant
a m o u n t so fl a t ep r o t e i n si naf e wo ft h ec e l l s( F i g u r e
6 B ) .P r e v i o u s l y ,w eh a v es h o w nt h a tag e n o m ed e f i c i e n t
in L4-22/33K expression during the intermediate phase
of infection (when these are needed to move the infec-
tious program on into the late phase; [19]) still made
some L2 penton base protein [17]. The polyclonal
serum used here detects this protein, meaning that the
positive late protein immunofluorescence signal in the
absence of L4 complementation may be accounted
for by penton base expression without full late protein
expression and consequent production of virus
occurring.
The LoxP/Cre RMCE strategy employed here to gen-
erate an Ad5 L4 complementing cell line could also be
used to create cell lines to complement other viral vec-
tors. Advantages of this system are that once the LoxP
parent cell lines have been characterised, they represent
a resource from which it is quick, easy and efficient to
generate cell lines with predetermined transgene expres-
sion profiles. Isolation of useful LoxP parent lines is
facilitated by prior cell sorting, which reduces the num-
ber of clones that need to be screened. As well as pro-
viding a means to isolate useful complementing cell
lines, the RMCE approach should permit comparative
studies of the functional properties of a series of trans-
genes, e.g. L4-100K mutant genes, without the con-
founding issue of variable expression levels.
Conclusions
RMCE is a powerful tool in the recombineering of
mammalian cell lines. This study has highlighted the
potential of this approach for the generation of comple-
menting cell lines for the growth of gene-deleted virus
vectors by utilizing one of a series of LoxP parent 293
cell lines to generate an Ad5 L4-complementing cell line
that was able to support the propagation of L4-mutant
Ad5 viruses. The generation of further Ad5 comple-
menting cell lines from any of the LoxP parent cell lines
isolated here should be facilitated as the cell lines
obtained will have predetermined expression properties.
Methods
Construction of pLoxPhrGFPzeo (pLoxPGFP) and pShuttle-
100/22/33KFLAG
These plasmids have been briefly reported as peripheral
to a previous study [40] but are described here in detail.
pLoxPhrGFPzeo (pLoxPGFP) was generated by modifi-
cation of pBiEGFPPacI [19]. The eGFP gene was
removed by SpeI/HindIII digest and a LoxP adaptor
molecule with NheI (5’)a n dX b a I( 3 ’) compatible ends
(CTAGCGGGGGCGCCGGGATCGATATA-
TAACTTCGTATAGCATACATTATACGAAGTTATT-
TAATTAAGGGAAGCTTGGGT) inserted together
with the NheI/HindIII fragment from phrGFP-N1
(Clontech) to generate pLoxPhrGFP. Orientation of the
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t a n c eg e n e( Z e o
R) and SV40 polyadenylation sequence
was amplified from pZeoSV2+ (Invitrogen) and digested
with MluI/NheI while the thymidine kinase promoter
(PTK) was amplified from pTKHyg
R (Clontech) and
digested with MluI. The two digested PCR products
were then cloned into pLoxPhrGFP to generate
pLoxPhrGFPzeo, with hrGFP under control of the PBi
promoter and Zeo
R under Ptk control.
The LoxP-L4 shuttle plasmid (pShuttle100/22/
33KFLAG) was constructed from pBiEGFPPacI [19].
The PTK-Hyg
R cassette from pTKHyg
R (Clontech) was
amplified and inserted into pBiEGFPPacI which had
been digested with SapI and then treated with DNApolI
(Klenow fragment) to blunt the termini. The resulting
plasmid, pBiEGFP-HYG
R was then further modified by
exchanging the PBi-EGFP expression cassette for the
LoxP adaptor molecule above to create a promoterless
hygromycin-selectable plasmid, pLoxPshuttle. The L4
cassette for insertion into this plasmid comprised the
Ad5 tripartite leader (TPL; Ad 6049-6089, 7111-7182,
9644-9733) and 109 bp intron sequence downstream of
leader 3 (Ad 9734-9842), joined to Ad5 L4 sequence
from 198 bp upstream of 100K ORF (Ad 23863-27086)
(Figure 4B). The TPL (Ad 6049-9731) was amplified by
RT-PCR from mRNA isolated from cells infected with
Ad5 wt300 virus using a 5’ primer containing a PacI
recognition site. The 5’ end of the intron was generated
by amplification of Ad5 9275-9868 from Ad5 wt300
genomic DNA using a 3’ primer with SalI and HindIII
recognition sites. The XhoI site at position Ad 9699 pre-
sent in both PCR products was used to join them. This
was then ligated into pLoxPshuttle as a PacI/HindIII
fragment to generate pShuttle-TPL. The 3’ end of the
intron and part of the L4-ORF (Ad 23863-26504) was
amplified from pE2BS, a clone of Ad5 wild-type BamHI
(21562) - SpeI (27082) fragment, using a 5’ primer with
a SalI recognition site. The 3’ end of the L4 cassette,
including the sequence for a C-terminal FLAG tag, was
excised from pCMV33KFLAG [17] as a HindIII/XbaI
fragment. The HindIII site at position Ad26328
was used to join the two fragments prior to inserting
into pShuttle-TPL at PacI/XbaI to give pShuttle100/
22/33KFLAG, containing a promoterless L4 cassette
(Figure 4B).
Generation of LoxP parent and A1-L4 cell lines
293TETOFF cells (Clontech) were maintained in DMEM
supplemented with 10% (v/v) Tet-system approved fetal
calf serum (FCS; Clontech) and 100 μg/ml geneticin
(G418; Melford). To obtain LoxP parent lines, cells were
seeded into poly-D-Lysine coated 6-well plates at a den-
sity of 1.5 × 10
6 cells/well prior to being transfected with
1 μg pLoxPGFP using Lipofectamine2000 (LF2000) at a
ratio of 1 μgD N A :3μl LF2000. 24 h post transfection,
cells were analysed under UV light for the expression of
GFP before the media was changed for media supple-
mented with 60 μg/ml Zeocin (Invitrogen) and 100 ng/
ml doxycycline (Dox; Sigma). Cells were selected for Zeo-
cin resistance for 28 days. Cells were then grown in the
absence of Dox for 7 days, with daily media changes, to
induce GFP expression and then trypsinised and resus-
pended in serum-free DMEM at a concentration of 5 ×
10
5 cells/ml for sorting into high and low GFP popula-
tions using a FACSVantage SE (Becton Dickinson) with
488 nm argon excitation laser and 530 nm narrow band
pass filter in the normal-R sort mode. FACS data was
analysed using WinMDI version 2.9. Sorted cells were
seeded into 6 well plates at low density in the presence of
Zeocin and Dox and individual LoxP parent cell clones
isolated.
To obtain A1-L4 cells, LoxP parent Clone A1 was
transfected with 1 μg pShuttle100/22/33KFLAG together
with 500 ng Cre recombinase expression plasmid (pCre;
[pBS185, Invitrogen]) using LF2000. From 24 h post-
transfection, cells were maintained in media supplemen-
ted with 100 μg/ml hygromycin (Roche) and 100 ng/ml
Dox to isolate hygromycin-resistant clones. The location
of the inserted L4-cassette with respect to the PBi pro-
moter was confirmed by PCR from genomic DNA using
primers specific for the promoter and for TPL leader 3.
Southern blot analysis
Genomic DNA was isolated from cells using Tri-reagent
(Sigma) according to the manufacturer’si n s t r u c t i o n s .
20 μg DNA was digested with EcoRI or KpnI, resolved
through 1% (w/v) agarose gel and transferred to
Hybond-N nylon membrane (GE Healthcare) alongside
similarly digested pLoxPGFP (1 ng, mixed with 19 μg
salmon sperm DNA) as a control. DNA was detected
using the 763 bp HindIII fragment from pLoxPGFP,
containing the GFP gene, labelled using the AlkPhos
direct labelling kit (GE Healthcare).
Generation of ΔL4 virus genome
pE2BS was modified to delete parts of the 100K, 22K
and 33K ORF while retaining the E2 regulatory
sequences present on the opposite strand of Ad5 gen-
ome from the L4 region. PCR with pE2BS as template
was used to generate Ad 23854-24047, using a 3’ primer
containing HindIII/NsiI sites, and Ad 26922-27102,
using a 5’ primer containing HindIII/XbaI sites. These
products were cloned into pE2BS as a SmaI-HindIII-
SpeI fragment to generate pE2BSΔ1. The same approach
was used to give Ad 24555-24853, using a 5’ primer
containing a PstI site, and Ad 25738-25930, using a 5’
primer containing a SalI site and 3’ primer containing
an NheI site. These PCR products were inserted as a
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pE2BSΔ1 to generate pE2BSΔL4. Finally, ΔL4 virus gen-
ome was generated by ligation of the BamHI/SpeI frag-
ment (Ad 21563-24047, 24555-24796, 25738-25930,
26922-27081) from pE2BSΔL4 to left arm (Ad
1- BamHI 21562) and right arm (Ad SpeI 27082-35938)
fragments from Ad5 wt300 genomic DNA. The resulting
genome thus contains substantial deletions within the
L4-100K, -22K and -33K coding sequences.
Complementation Studies
pBiL1-3NheI (pBiL1-3), pCMVFLAG, pCMV22/
33KFLAG and pCMV100KFLAG, and the analysis of
gene expression from pBiL1-3, have been described pre-
viously [17,19]. For virus rescue, linear genome was pre-
pared by PacI digestion of pTG3602-Ad5wt (pWT),
which contains the complete wild-type Ad5 genome
[46], and pTG3602-Δ47 (pΔ47), which carries the full
genome with two stop codon mutations within the
L4-33K ORF that result in a protein with a 47aa trunca-
tion of its C-terminus [41]. 293TETOFF cells or Clone
A1-L4 cells were grown in the absence of Dox for 3
days, seeded into 6-well plates and transfected with 500
ng WT, Δ47 or ΔL4 genome using LF2000 as described
above. Once extensive cpe was observed, cells and med-
ium were harvested and subjected to three rounds of
freeze thawing to generate virus stock P1, which was
then passaged in fresh cells to generate virus P2.
293TETOFF or Clone A1-L4 were infected with 1/15
volume of each total P2 stock (grown in the absence of
Dox) for phenotypic analysis. The mutant genotype of
ΔL4 virus was confirmed by PCR analysis using purified
packaged viral DNA [47] and primers hybridising to Ad
genome with 5’ ends at positions 23863 and 27086.
Western blotting and immunofluorescence
Western blotting and immunofluorescence were carried
out as previously described [48,49]. Proteins were
detected using the following primary antibodies: anti-
FLAG rabbit polyclonal serum (Sigma) at 1:1000;
AbJLB1 rabbit polyclonal serum to Ad5 late proteins at
1:10,000 for western blotting and 1:1000 for immuno-
fluorescence [19]; rabbit anti-L4-100K (W. C. Russell,
University of St Andrews) at 1:10,000 for western
blotting and 1:1000 for immunofluorescence; mouse
anti-DNA binding protein MAb B6-8 at 1:100 [50].
Secondary antibodies used for these studies were goat-
anti-mouse IgG-horseradish peroxidise (HRP) conjugate
(Sigma) at 1:5000 and goat-anti-rabbit IgG-HRP (Santa
Cruz) at 1:100,000 for western blotting, and Alexa-
fluor594 goat-anti-rabbit IgG (Invitrogen) and Alexa-
fluor488 goat anti-mouse IgG (Invitrogen) each at 1:500
for immunofluorescence.
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